Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-03

FDA Approved: CORTIFOAM — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for Cortifoam (hydrocortisone acetate) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CORTIFOAM (HYDROCORTISONE ACETATE)

Snippet

SUPPL AP for CORTIFOAM (HYDROCORTISONE ACETATE)